logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Еffect of monoclonal antibodies to neuroreceptors on cyclic AMP contents in rat lymphocytes

[Abstracts]
Mariya Baturina; Ekaterina Vladimirovna Grudina; Eduard Beyer;

The study implied analyzing the effect that monoclonal antibodies (IgG) to dopamine receptors Type 1 and 2 (DR1 and DR2) and NMDA receptors (NR2A NR2B subunits) have on the cyclic AMP (c-AMP) levels of isolated lymphocytes. Per each antibody there were solutions prepared at concentrations of 3 ng/ml, 30 ng/ml and 300 ng/ml, as well as the Antibody combinations were prepared: NR2A+DR1; NR2A+DR2; NR2B+DR1; NR2B+DR2. Solutions with the concentration of each antibody were prepared for each combination: 3x300 ng/ml; 30x30 ng/ml; 300x3 ng/ml. Isolated blood lymphocytes of healthy rats were treated in vitro with solutions of antibodies and their combinations. The control series of experiments relied on a solution containing no antibodies. All solutions containing individual antibodies had a greater reducing effect on the c-AMP level in lymphocytes if compared to the control series. The most significant decrease in c-AMP was obtained using antibodies to NR2A at concentrations of 30 and 300 ng/ml, antibodies to NR2B 3 and 300 ng/ml. Solutions of antibodies to DR1 reduced c-AMP more strongly than antibodies to DR2. A combination of antibodies in solutions resulted in a mutually enhanced or weakened effect. Potentiation of the effect of antibodies with a significant decrease in c-AMP levels was identified when using NR2A+DR2 at concentrations of 3x300 ng/ml. The effect of antibodies on the c-AMP level could be eliminated through using antibodies to NR2A+DR1 (concentrations: 30x30 ng/ml) and NR2B+DR1 (300x3 ng/ml). In these cases, the c-AMP levels in lymphocytes featured no difference from the control series of experiments. In case there was a combination of NR2A+DR2 antibodies at a concentration of 30x30 ng/ml, the effect on the c-AMP content proved weakened.

Download

References:
1. Kuzmina U. S., Bakhtiyarova K. Z., Vakhitova Y. V. Cellular mechanisms of neuroimmune in multiple sclerosis: ionotropic glutamate receptors of T-lymphocytes. Medicinskij akademicheskij zhurnal. – Medical academic journal. 2019;19(1):86-88. (In Russ.). https://doi.org/10.17816/MAJ191S186-88
2. Boldyrev A. A., Bryushkova E. A., Vladychenskaya E. A. NMDA receptors in cells of the immune system. Biohimiya. – Biochemistry. 2012;77(2):160-168. (In Russ.).
3. Taraskina A. E., Nasyrova R. F., Grunina M. N., Zabotina A. M., Ivashchenko D. V. [et al.]. Dopamine neurotransmission of peripheral blood lymphocytes is a potential biomarker of psychiatric and neurological disorders. Zhurnal nevrologii i psihiatrii im. S. S. Korsakova. – Journal of Neurology and Psychiatry named after S. S. Korsakov. 2015;115(9):65-69. (In Russ.). https://doi.org/10.17116/jnevro20151159165-69
4. Baturina M. V., Beier E. V., Boev O. I. Neuroleptics chromic administration influence in the blood levels of neuro-specific autoantibodies in rats. Meditsinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2020;15(2):243-246. (In Russ.). https://doi.org/10.14300/mnnc.2020.15057
5. Baturina M. V. Analysis of the effect of serum autoantibodies to neuroreceptors on changes in the concentration of cyclic AMP in isolated rat lymphocytes. Meditsinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2024;19(1):62-64. (In Russ.). https://doi.org/10.14300/mnnc.2024.19015

Keywords: antibodies, NMDA receptors, dopamine receptors, lymphocytes, cyclic AMP


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy